Skip to main content
. 2024 Nov 13;15:1469390. doi: 10.3389/fpsyt.2024.1469390

Table 2.

Summary statistics for sociodemographic data, neuropsychological test scores, sense of Self questionnaires, and psychopathological data, by Group.

FEP
N = 10
CTL
N = 35
Yuen test
Mean (SD) Mean (SD) Mdiff Yt p
Sociodemographic
 Age (years) 19.8 (3.39) 22.1 (4.24) 1.76 [-1.35, 4.87] 1.32 0.24
 Sex:
  Female 6 (60.0%) 21 (60.0%)
  Male 4 (40.0%) 14 (40.0%)
 Years of education 11.9 (2.13) 14.1 (2.12) 2.10 [0.91, 3.28] 3.69 0.003
Neuropsychology
 WAIS Vocabulary (age-scaled score) (/19) 10.3 (3.47) 9.57 (3.54) -0.52 [-5.39, 4.34] -0.33 0.75
 TMT B-A (Z-score) 1.15 (1.27) 1.39 (3.62) -0.91 [-2.31, 0.49] -1.57 0.18
Sense of Self
 MAIA-2 – Total (/40) 21.6 (5.03) 23.8 (3.28) 0.99 [-2.30, 4.29] 0.77 0.48
 MAIA-2 – Noticing (/5) 3.12 (0.68) 3.53 (0.73) 0.31 [-0.25, 0.87] 1.24 0.23
 MAIA-2 – Not-Distracting (/5) 2.38 (0.65) 2.06 (0.72) -0.30 [-0.90, 0.31] -1.20 0.27
 MAIA-2 – Not-Worrying (/5) 2.34 (1.03) 2.59 (0.99) 0.44 [-0.27, 1.15] 1.44 0.19
 MAIA-2 – Attention Regulation (/5) 2.49 (0.81) 2.90 (0.67) 0.31 [-0.19, 0.81] 1.29 0.22
 MAIA-2 – Emotional Awareness (/5) 3.10 (1.00) 3.59 (0.87) 0.5 [-0.13, 1.14] 1.77 0.11
 MAIA-2 – Self-Regulation (/5) 2.58 (1.06) 2.88 (0.71) 0.36 [-0.83, 1.56] 0.93 0.40
 MAIA-2 – Body Listening (/5) 2.07 (0.90) 2.66 (1.00) 0.49 [-0.18, 1.17] 1.68 0.13
 MAIA-2 – Trust (/5) 3.50 (1.52) 3.62 (1.11) -0.04 [-1.76, 1.69] -0.06 0.96
 TSCS-2 –Total (/105) 76.3 (9.70) 85.3 (8.31) 10.14 [3.05, 17.24] 3.34 0.01
 TSCS-2 – Conflict (/-15) -13.90 (4.84) -12.29 (5.02) 1.17 [-2.88, 5.21] 0.69 0.52
 TSCS-2 – Inconsistency (/4) 1.10 (0.88) 0.86 (0.97) -0.38 [-0.84, 0.08] -1.67 0.10
 TSCS-2 – Response Distribution (/21) 5.80 (3.94) 9.49 (3.95) 4.52 [-0.16, 9.21] 2.75 0.05
 TSCS-2 – Physical (/25) 17.5 (2.68) 19.1 (2.83) 1.64 [-0.62, 3.9] 1.86 0.11
 TSCS-2 – Moral (/20) 13.6 (1.96) 16.4 (1.77) 3.14 [1.13, 5.16] 3.98 0.01
 TSCS-2 – Personal (/25) 17.2 (3.85) 19.9 (2.72) 2.98 [-0.28, 6.23] 2.13 0.07
 TSCS-2 – Familial (/20) 17.3 (2.54) 18.0 (2.66) 1.05 [-1.28, 3.38] 1.09 0.33
 TSCS-2 – Social (/15) 10.7 (2.45) 11.8 (2.02) 1.14 [-1.75, 4.04] 1.12 0.33
Psychopathology
 BPRS – Total (/168) 51.3 (11.4)
 PANSS – Total (/210) 72.9 (16.0)
 PANSS – Positive (/49) 14.5 (5.44)
 PANSS – Negative (/49) 21.7 (6.60)
 PANSS – General psychopathology (/112) 36.7 (7.44)
 NSSE – Total (/69) 12.3 (6.05)
 NSSE – Motor coordination (/24) 6.67 (4.34)
 NSSE – Motor integration (/18) 1.39 (1.24)
 NSSE – Sensory integration (/15) 2.19 (1.87)
 NSSE – Involuntary movements (/6) 0.39 (0.70)
 NSSE – Lateralisation (/6) 0.56 (0.73)
 SOFAS – Last year (/100) 50.6 (7.65)
 SOFAS – Last month (/100) 53.7 (8.83)
 SPQ – Total (/32) 11.7 (6.08)
 SPQ – Positive (/14) 3.65 (2.90)
 SPQ – Negative (/10) 4.29 (2.81)
 SPQ – Disorganisation (/8) 3.79 (2.11)
Medication
 Chlorpromazine equivalent dose (mg) 616 (574)

FEP, first-episode psychosis patients; CTL, healthy controls; Mdiff, trimmed mean difference with 95% confidence interval; Yt, Yuen test statistic; p, Yuen test p-value; WAIS, Wechsler Adult Intelligence Scale; TMT, Trail Making Test; MAIA-2, Multidimensional Assessment of Interoceptive Awareness – Version 2; TSCS-2, Tennessee Self-Concept Scale – Second Edition, Short Form. BPRS, Brief Psychiatric Rating Scale – Expanded; PANSS, Positive And Negative Symptoms Scale; NSSE, Neurological Soft Signs Examination; SOFAS, Social and Occupational Functioning Assessment Scale; SPQ, Schizotypal Personality Questionnaire – Brief Revised. In bold: statistically significant results.